Innovate combination of sevoflurane dilution in dimethyl sulfoxide: A stability study by gas chromatography and nuclear magnetic resonance
F Dámaso Fernández-Ginés, Carmen Fernández-Sánchez, Department of Pharmacy, Torrecárdenas Hospital, 04009 Almería, Spain
Sergio García-Muñoz, University of Almería, 04120 Almería, Spain
Héctor Mateo-Carrasco, Aseptic Services Unit, Department of Pharmacy, Northampton General Hospital, Northampton NN1 5BD, United Kingdom
Miguel Ángel Rincón-Cervera, Institute of Nutrition and Food Technology, University of Chile, 1058 Santiago, Chile
Manuel Cortiñas-Sáenz, Department of Anesthesiology and Pain Management, Torrecárdenas Hospital, 04009 Almería, Spain
José Antonio Morales-Molina, Department of Pharmacy, Agencia Pública Empresarial Sanitaria Hospital de Poniente, El Ejido, 04700 Almería, Spain
Juan Miguel Expósito-López, Ignacio Rodríguez-García, Department of Chemistry and Physics, University of Almería, 04120 Almería, Spain
Author contributions: Fernández-Ginés FD, García-Muñoz S and Mateo-Carrasco H contributed equally to this work; Rincón-Cervera MÁ participated in the acquisition, analysis, and interpretation of chromatograms; Cortiñas-Sáenz M, Morales-Molina JA and Fernández-Sánchez C were the guarantor and designed the study; Expósito-López JM participated in the acquisition, analysis, and interpretation of nuclear magnetic resonance spectra; Rodríguez-García I revised the article critically for important intellectual content.
Institutional review board statement: This research has not involved human and/or animal subjects, hence none IRBS was required.
Informed consent statement: This research has not involved human and/or animal subjects, hence none ICS was required.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Héctor Mateo-Carrasco, MPharm, PhD, MRPharmS, Specialist Pharmacist Cancer Services, Aseptic Services Unit, Department of Pharmacy, Northampton General Hospital, Cliftonville Road, Northampton NN1 5BD, United Kingdom. email@example.com
Received: April 8, 2016
Peer-review started: April 11, 2016
First decision: July 21, 2016
Revised: July 26, 2016
Accepted: August 30, 2016
Article in press: August 31, 2016
Published online: September 9, 2016